BE IMMUNE: Behavioral Economics to Improve Flu Vaccination Using EHR Nudges

Sponsor
University of Pennsylvania (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06057727
Collaborator
National Institute on Aging (NIA) (NIH), University of Washington (Other)
79,857
2
3
8.2
39928.5
4880.8

Study Details

Study Description

Brief Summary

This study will be a multisite, cluster randomized, pragmatic trial to evaluate the effectiveness of personalized nudges to clinicians and patients, relative to a control, to increase flu vaccination rates among older adults in accordance with CDC guidelines. This will include clinician and patient level nudge interventions, with an additional, intensified nudge intervention for patients identified as high risk for not receiving a flu vaccine. Among the intervention clinics, patients will receive pre-visit text message reminders about the flu vaccine, and clinicians will receive a default pended order in the visit encounter in the EHR, along with monthly peer comparison feedback about their flu vaccine completion rate. Patients identified as high risk for noncompletion will be individually randomized to receive an additional bidirectional text message nudge or the standard text messaging.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Pre-visit patient text messaging
  • Behavioral: Default pended order
  • Behavioral: Monthly peer comparison feedback
  • Behavioral: High risk bidirectional pre-visit text messaging
N/A

Detailed Description

Many older adults are at risk of illness, hospitalization, and death from vaccine-preventable diseases. More than half of older adults in the United States are not vaccinated for flu which has remained relatively constant over the past decade, and there are racial, ethnic, and socioeconomic disparities in care. In this study, we will evaluate personalized nudges to clinicians and patients to help increase flu vaccination rates during primary care visits among older adults, with a particular focus on population subgroups at high risk for vaccine noncompletion. In a partnership between Penn Medicine and University of Washington (UW) Medicine, this will be a 6-month, multisite, cluster randomized, pragmatic trial with an additional intensification arm for high-risk patients.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
79857 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
We will randomize primary care clinics 2:1 to the intervention arm or control arm using covariate-constrained randomization. Patients identified as at high-risk for non-completion of the flu vaccine will be additionally randomized 1:1 at the individual level to receive an additional intensification nudge compared with the multi-component nudge intervention alone.We will randomize primary care clinics 2:1 to the intervention arm or control arm using covariate-constrained randomization. Patients identified as at high-risk for non-completion of the flu vaccine will be additionally randomized 1:1 at the individual level to receive an additional intensification nudge compared with the multi-component nudge intervention alone.
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Health Services Research
Official Title:
BE IMMUNE: Behavioral Economics to IMprove and Motivate Vaccination Using Nudges Through the EHR
Anticipated Study Start Date :
Sep 25, 2023
Anticipated Primary Completion Date :
Feb 28, 2024
Anticipated Study Completion Date :
May 31, 2024

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control

Clinics randomized to the control arm will receive standard of care.

Experimental: Intervention Arm

Clinics randomized to the intervention arm will receive the toolkit of clinician and patient facing nudges. Patient nudges will be pre-visit text message reminders (standard messaging content). Clinician nudges will be monthly peer comparison feedback and default pended orders.

Behavioral: Pre-visit patient text messaging
Patients will be sent text message reminders 3 days and 24 hours prior to their scheduled primary care visit. The messages will inform the patient that a flu shot has been reserved for them at their upcoming appointment and encouraging the patient to ask their provider about receiving the vaccine.

Behavioral: Default pended order
A default pended order for the flu vaccine will be pended to the patient's upcoming primary care encounter and will be visible to the provider during the visit encounter. Clinical staff will have the option of signing the order or dismissing it if they deem it inappropriate for a given patient.

Behavioral: Monthly peer comparison feedback
Each month, clinicians will be sent an email containing what percent of their eligible patients received the flu vaccine and how that compares to other peer clinicians in the intervention.

Experimental: High Risk Intensification Arm

Patients in the intervention clinics identified as high risk for noncompletion of the flu vaccine will be randomized 1:1 to receive the high risk intensification arm or remain in the standard intervention arm. Patients in the high risk intensification arm will receive an additional bidirectional texting component.

Behavioral: Pre-visit patient text messaging
Patients will be sent text message reminders 3 days and 24 hours prior to their scheduled primary care visit. The messages will inform the patient that a flu shot has been reserved for them at their upcoming appointment and encouraging the patient to ask their provider about receiving the vaccine.

Behavioral: Default pended order
A default pended order for the flu vaccine will be pended to the patient's upcoming primary care encounter and will be visible to the provider during the visit encounter. Clinical staff will have the option of signing the order or dismissing it if they deem it inappropriate for a given patient.

Behavioral: Monthly peer comparison feedback
Each month, clinicians will be sent an email containing what percent of their eligible patients received the flu vaccine and how that compares to other peer clinicians in the intervention.

Behavioral: High risk bidirectional pre-visit text messaging
High risk patients randomized to receive the high risk intensification nudge will receive a bidirectional text messaging component prior to their visit. This intervention will query the patient about common questions or concerns about receiving the flu vaccine. If the patient responds, it will provide additional educational materials based on the patient's specific concern(s).

Outcome Measures

Primary Outcome Measures

  1. Proportion of patients who receive the flu vaccine at the visit [4 days from enrollment, at the eligible visit]

    The primary outcome is flu vaccination completion during the first eligible primary care visit.

Secondary Outcome Measures

  1. Proportion of patients who receive the flu vaccine within 3 months after the visit [3 months]

    The secondary outcome is flu vaccination completion within 3 months after the first eligible primary care visit.

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Patient Inclusion Criteria:
All patients must meet the following criteria to be eligible:
  1. Age >50 years

  2. A scheduled new or return (non-urgent/sick) primary care appointment at one of the study practices at the Penn Medicine, UW Medicine, or Sutter Health

  3. Have not received their annual flu vaccine during the active intervention period (September- February)

  4. Eligible to receive the flu vaccine

For the high risk intensification nudge, at least one of the following criteria must be met to be considered high risk and randomized to receive the intensification nudge:

  1. Age ≥ 70 years

  2. Living in a lower income community (lowest quartile, zip-code based)

  3. Did not receive a flu vaccine in the previous calendar year

  4. Self-identifies as Non-Hispanic Black

Patient Exclusion Criteria:
  1. Have a documented allergy to flu vaccine

  2. Have a flu vaccine exclusion modifier in Health Maintenance

  3. Have opted out of research according to individual site guidelines and policies

  4. Have no phone number (home or mobile) listed in their chart

Clinician Inclusion Criteria:

Clinicians must meet the following criteria to be eligible to receive peer comparison feedback:

  1. Practicing physician (MD, DO) or advanced practice provider (NP, PA) with the exception of residents and fellows

  2. Have a minimum patient panel of at least 50 patients, and

  3. Practicing at a clinical site randomized to receive the clinic-level nudge interventions.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Pennsylvania Health System Philadelphia Pennsylvania United States 19104
2 University of Washington Seattle Washington United States 98195

Sponsors and Collaborators

  • University of Pennsylvania
  • National Institute on Aging (NIA)
  • University of Washington

Investigators

  • Principal Investigator: Shivan Mehta, MD,MBA,MSHP, University of Pennsylvania

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Shivan J Mehta, Associate Chief Innovation Officer, Associate Professor of Medicine, University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT06057727
Other Study ID Numbers:
  • 851838
  • R33AG068945
First Posted:
Sep 28, 2023
Last Update Posted:
Sep 28, 2023
Last Verified:
Sep 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Shivan J Mehta, Associate Chief Innovation Officer, Associate Professor of Medicine, University of Pennsylvania

Study Results

No Results Posted as of Sep 28, 2023